GlassScriptPhysician profile
Ellen H Colgan
NPI 1013304948
$9,842.06
in general payments reported to CMS, 2019-2025
20 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $581 · 2021: $1,364 · 2022: $2,298 · 2023: $3,521 · 2024: $813 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537 · Travel and Lodging: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.15 |
| Travel and Lodging | $1,403.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,341.26 | 2019-2025 | Augment Injectable, Easyfuse, Allofiber |
| Treace Medical Concepts, INC. | $2,256.61 | 2023-2025 | |
| Elite Orthopedics, LLC | $1,809.74 | 2019-2025 | |
| Organogenesis INC. | $991.06 | 2020-2025 | Puraply, Simplimax, Affinity |
| Integra Lifesciences Corporation | $749.94 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $385.36 | 2019-2024 | Grafix Pl, Stravix, Stravix Pl |
| Kerecis Limited | $305.56 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Abbott Laboratories | $181.14 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $168.79 | 2023 | Seglentis |
| Tactile Systems Technology INC | $120.92 | 2020 | |
| Abbvie INC. | $119.26 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $116.45 | 2021-2023 | Jublia |
| Paragon 28, INC. | $99.68 | 2023 | Portfolio |
| Biocomposites INC | $55.59 | 2019 | |
| Veryan Medical Incorporated | $37.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $33.82 | 2020 | |
| Bioventus LLC | $29.76 | 2019-2021 | |
| Orthofix Medical, INC. | $13.82 | 2019 | |
| Osiris Therapeutics INC. | $12.98 | 2019 | |
| Misonix INC | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Colgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.